Compare POWL & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | POWL | BLCO |
|---|---|---|
| Founded | 1947 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Electrical Products | Ophthalmic Goods |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 5.9B |
| IPO Year | 1995 | 2022 |
| Metric | POWL | BLCO |
|---|---|---|
| Price | $252.06 | $15.73 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 12 |
| Target Price | ★ $184.25 | $18.45 |
| AVG Volume (30 Days) | ★ 482.0K | 358.7K |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.14% | N/A |
| EPS Growth | ★ 20.91 | N/A |
| EPS | ★ 3.40 | N/A |
| Revenue | $448,716,000.00 | ★ $5,101,000,000.00 |
| Revenue This Year | $11.20 | $8.65 |
| Revenue Next Year | $9.12 | $5.59 |
| P/E Ratio | $76.39 | ★ N/A |
| Revenue Growth | ★ 13.34 | 6.47 |
| 52 Week Low | $164.26 | $10.45 |
| 52 Week High | $612.50 | $18.92 |
| Indicator | POWL | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 34.61 | 40.76 |
| Support Level | $251.55 | $14.39 |
| Resistance Level | $252.01 | $16.97 |
| Average True Range (ATR) | 11.98 | 0.37 |
| MACD | 8.34 | -0.06 |
| Stochastic Oscillator | 74.33 | 9.31 |
Powell Industries Inc is a United States-based company that develops, designs, manufactures, and services custom-engineered equipment and systems for electrical energy distribution, control, and monitoring. The company's principal products comprise integrated power control room substations, custom-engineered modules, electrical houses, traditional and arc-resistant distribution switchgear and control gear, and so on. These products are applied in oil and gas refining, offshore oil and gas production, petrochemical, pipeline, terminal, mining and metals, light-rail traction power, electric utility, pulp and paper, and other heavy industrial markets. The company generates the majority of its sales from the United States, and the rest from Canada, Europe, Asia Pacific, and other regions.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.